Half-year report · Q2
1757.TEDINET S100WHKW
Period2024-04-01 → 2024-09-30
Filed2025-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100USBZ. Amended by S100WHQR (2025-08-07).
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥992m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥963m | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥223m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | −¥207m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | −¥264m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | −¥222m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥595m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥283m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥433m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥279m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥434m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥591m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥282m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥434m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | −¥282m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥3.0bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.1bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.5bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.0bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥493m | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥324m | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥318m | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥30m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥232m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥30m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥232m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19m | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥67m | at 2023-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥652m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥804m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥495m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥31m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥498m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥495m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥481m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥942m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-1.52 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.22 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.07 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 16.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 29
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥179m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥845m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥845m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥22m |
| jpcrp040300-q2r_E00288-000House Produce Segmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥103m |
| jpcrp040300-q2r_E00288-000House Produce Segmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥103m |
| jpcrp040300-q2r_E00288-000House Produce Segmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4m |
| jpcrp040300-q2r_E00288-000Medical Segmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥30m |
| jpcrp040300-q2r_E00288-000Medical Segmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥30m |
| jpcrp040300-q2r_E00288-000Medical Segmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥979m |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥979m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | −¥15m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥15m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥231m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥180m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥180m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥43m |
| jpcrp040300-q2r_E00288-000Cosmetic Hygiene Related Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥8m |
| jpcrp040300-q2r_E00288-000Cosmetic Hygiene Related Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥8m |
| jpcrp040300-q2r_E00288-000Cosmetic Hygiene Related Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥5m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥188m |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥188m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | −¥48m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 563
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00288-000ConstructionWorkReportableSegmentsMember | 180013000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00288-000CosmeticHygieneRelatedBusinessReportableSegmentsMember | 8391000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 188405000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 34784000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 223189000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00288-000ConstructionWorkReportableSegmentsMember | -43019000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00288-000CosmeticHygieneRelatedBusinessReportableSegmentsMember | -5251000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | -48270000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 15382000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -230653000 | JPY |
| Operating income | Prior1YTDDuration | -263542000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00288-000ConstructionWorkReportableSegmentsMember | 845139000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00288-000HouseProduceSegmentReportableSegmentMember | 103491000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00288-000MedicalSegmentReportableSegmentMember | 30393000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 979024000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 12501000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 991526000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00288-000ConstructionWorkReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00288-000HouseProduceSegmentReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00288-000MedicalSegmentReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00288-000ConstructionWorkReportableSegmentsMember | 845139000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00288-000HouseProduceSegmentReportableSegmentMember | 103491000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00288-000MedicalSegmentReportableSegmentMember | 30393000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 979024000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 12501000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 991526000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00288-000ConstructionWorkReportableSegmentsMember | -22198000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00288-000HouseProduceSegmentReportableSegmentMember | 4180000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00288-000MedicalSegmentReportableSegmentMember | 2696000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | -15321000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -12344000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -179081000 | JPY |
| Operating income | CurrentYTDDuration | -206748000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書（2025年８月７日付け訂正報告書の添付インラインXBRL） | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-11-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第61期中（自 2024年４月１日 至 2024年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社創建エース | |
| Company name in english cover page | FilingDateInstant | Souken Ace Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長兼社長 西山 由之 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都新宿区西新宿一丁目25番１号 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |